Showing results (881-890 of 1,038) with videos related to
Sort By:
Pageof 104
JCO Precision Oncology|January 20, 2022
Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult OncologySusan J Hsiao, Anthony N Sireci, Danielle Pendrick, et al.Inorganic Chemistry|January 6, 2009
Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquineChandima S K Rajapakse, Alberto Martínez, Becky Naoulou, et al.Ophthalmic Surgery, Lasers & Imaging Retina|April 22, 2026
Universal Newborn Eye Screening in São Paulo, BrazilPauline Scherm, Devi K Schwartz, Marcelo Alexandre Agra Cavalcante Costa, et al.The American Journal of Tropical Medicine and Hygiene|October 1, 1989
Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villagesP Deloron, G H Campbell, D Brandling-Bennett, et al.Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1991
Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malariaJ A Sherwood, C N Oster, M Adoyo-Adoyo, et al.Investigational New Drugs|May 11, 2002
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neckDavid G Pfister, John McCaffrey, Andrew J Zahalsky, et al.The American Journal of Clinical Nutrition|February 17, 2012
Choline intake in a large cohort of patients with nonalcoholic fatty liver diseaseAnthony L Guerrerio, Ryan M Colvin, Amy K Schwartz, et al.PM & R : the Journal of Injury, Function, and Rehabilitation|February 13, 2019
Classification of Mild Stroke: A Mapping ReviewJaclyn K Schwartz, Carmen E Capo-Lugo, Abiodun Emmanuel Akinwuntan, et al.The Lancet. Oncology|January 27, 2018
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trialsSandra P D'Angelo, Michelle R Mahoney, Brian A Van Tine, et al.Pageof 104